These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 30200166)
1. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study. Lin SP; Wu CY; Wang CB; Li TC; Ko NY; Shi ZY Medicine (Baltimore); 2018 Sep; 97(36):e12268. PubMed ID: 30200166 [TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan. Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: A cross-sectional study. Yang CJ; Wang HY; Chou TC; Chang CJ J Microbiol Immunol Infect; 2019 Oct; 52(5):720-727. PubMed ID: 31358463 [TBL] [Abstract][Full Text] [Related]
4. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Butt AA; Fultz SL; Kwoh CK; Kelley D; Skanderson M; Justice AC Hepatology; 2004 Jul; 40(1):115-9. PubMed ID: 15239093 [TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE AIDS; 2007 Aug; 21(13):1739-45. PubMed ID: 17690572 [TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors. Wu PY; Hung CC; Liu WC; Hsieh CY; Sun HY; Lu CL; Wu H; Chien KL J Antimicrob Chemother; 2012 Apr; 67(4):1001-9. PubMed ID: 22232517 [TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon. Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Chen TY; Ding EL; Seage Iii GR; Kim AY Clin Infect Dis; 2009 Nov; 49(10):1605-15. PubMed ID: 19842982 [TBL] [Abstract][Full Text] [Related]
9. Incidence of Neurological Disorders Among HIV-Infected Individuals With Universal Health Care in Taiwan From 2000 to 2010. Tsai YT; Chen YC; Hsieh CY; Ko WC; Ko NY J Acquir Immune Defic Syndr; 2017 Aug; 75(5):509-516. PubMed ID: 28520614 [TBL] [Abstract][Full Text] [Related]
10. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS. Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849 [TBL] [Abstract][Full Text] [Related]
11. Obstructive sleep apnea among HIV-infected men in the highly active antiretroviral therapy era: a nation-wide longitudinal cohort study in Taiwan, 2000-2011. Chen YC; Lin CY; Li CY; Zhang Y; Ko WC; Ko NY Sleep Med; 2020 Jan; 65():89-95. PubMed ID: 31739231 [TBL] [Abstract][Full Text] [Related]
12. Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study. Rasmussen LD; Mathiesen ER; Kronborg G; Pedersen C; Gerstoft J; Obel N PLoS One; 2012; 7(9):e44575. PubMed ID: 22984529 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study. Lo YC; Chen MY; Sheng WH; Hsieh SM; Sun HY; Liu WC; Wu PY; Wu CH; Hung CC; Chang SC HIV Med; 2009 May; 10(5):302-9. PubMed ID: 19220492 [TBL] [Abstract][Full Text] [Related]
15. Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study. Falade-Nwulia O; Seaberg EC; Snider AE; Rinaldo CR; Phair J; Witt MD; Thio CL Ann Intern Med; 2015 Nov; 163(9):673-80. PubMed ID: 26457744 [TBL] [Abstract][Full Text] [Related]
16. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ; Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251 [TBL] [Abstract][Full Text] [Related]
17. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. Moodie EE; Pant Pai N; Klein MB PLoS One; 2009; 4(2):e4517. PubMed ID: 19223976 [TBL] [Abstract][Full Text] [Related]
18. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. Rasmussen LD; Engsig FN; Christensen H; Gerstoft J; Kronborg G; Pedersen C; Obel N AIDS; 2011 Aug; 25(13):1637-46. PubMed ID: 21646903 [TBL] [Abstract][Full Text] [Related]
19. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F; Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870 [TBL] [Abstract][Full Text] [Related]
20. Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy. Gali B; Eyawo O; Hull MW; Samji H; Zhang W; Sereda P; Lima VD; McGrail K; Montaner JSG; Hogg RS; Moore D; Curr Med Res Opin; 2019 Nov; 35(11):1955-1963. PubMed ID: 31315470 [No Abstract] [Full Text] [Related] [Next] [New Search]